Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos(Dana-Farber Cancer Institute), Stephen A. Cannistra(Beth Israel Deaconess Medical Center), Nancy Francoeur(Icahn School of Medicine at Mount Sinai), Douglas A. Levine(New York University), Dimitrios Spentzos(Beth Israel Deaconess Medical Center), Elena Fountzilas(St. Luke's Hospital), Beth Y. Karlan(University of California, Los Angeles), Toshiyasu Taniguchi(Tokai University)
Cited by 488
Related Papers
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k